Sio Capital Management »

Avalo Therapeutics Ord shares owned by Sio Capital Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $891k 72k 12.47
2024-03-31 $221k 10k 21.75

More positions owned by Sio Capital Management

Insmed Com Par $.01 Put Option (INSM)
Labcorp Holdings Com Shs (LH)
Teleflex Incorporated (TFX)
Zimmer Holdings (ZBH)
Smith & Nephew Spdn Adr New (SNN)
Pacira Pharmaceuticals Put Option (PCRX)
Organon & Co Common Stock (OGN)
GSK Sponsored Adr (GSK)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Vaxart Com New (VXRT)
Tyra Biosciences (TYRA)
Abbott Laboratories (ABT)
Cigna Corp (CI)
Kenvue (KVUE)
Disc Medicine (IRON)

View all positions for Sio Capital Management

Top funds holding Avalo Therapeutics Ord

Logos Global Management
Sio Capital Management
Ikarian Capital
Affinity Asset Advisors
Commodore Capital
Vanguard Group
Bank of America Corporation
Royal Bank of Canada
Banque Cantonale Vaudoise
BlackRock
Morgan Stanley
Efficient Wealth Management
Bnp Paribas Arbitrage, Snc
Group One Trading
Jpmorgan Chase & Co

View all funds holding Avalo Therapeutics Ord